SEC Company Response from ChronoScale Holdings Corp (CHRN) (CIK 0001549084) (CHRN) — Mar 30, 2026
ChronoScale Holdings Corp (CHRN) (CIK 0001549084)
Date: March 30, 2026 · CIK: 0001549084 · Accession: 0001437749-26-010425
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 001-37854
Referenced dates: March 27, 2026
Letter
ekso20260330_corresp.htm
Wilson Sonsini Goodrich & Rosati
Professional Corporation
650 Page Mill Road
Palo Alto, CA 94304-1050
O: 650.493.9300
f: 650.493.6811
March 30, 2026
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance Office of Technology
100 F Street, N.E.
Washington, D.C. 20549-3720
Attn:
Matthew Crispino
Jan Woo
Re:
Ekso Bionics Holdings, Inc.
Preliminary Information Statement
Filed March 20, 2026
File No. 001-37854
Ladies and Gentlemen:
On behalf of our client, Ekso Bionics Holdings, Inc. (the “ Company ”), we submit this letter in response to the comments contained in the letter dated March 27, 2026 (the “ Comment Letter ”) from the staff (the “ Staff ”) of the Securities and Exchange Commission (the “ SEC ”) relating to the above referenced Preliminary Information Statement on Schedule 14C (the “ Preliminary Information Statement ”) as filed by the Company on March 20, 2026. For your convenience, the text of the Staff’s comment is set forth below, by the Company’s response. Please note that all references to page numbers in the response below are references to the page numbers in Amendment No. 1 to the Preliminary Information Statement (the “ Amended Information Statement ”) submitted to the SEC concurrently with the submission of this letter.
Preliminary Information Statement
Opinion of Ekso’s Financial Advisor to the Board, page 41
1.
We note that in performing its analyses and rendering its fairness opinion, Ekso's financial advisor, Lake Street Capital Markets LLC, relied on, among other things, internal financial analyses and forecasts prepared by Cloud's management. Please disclose the financial projections and other financial information furnished to Lake Street in the information statement. Refer to Item 1015(b)(6) of Regulation M-A.
In response to the Staff’s comment, the Company has revised the disclosure on pages 45 and 46 of the Amended Information Statement.
If you have any questions or comments regarding this letter and the responses set forth above, please direct the questions to me at (512) 338-5410 or amarch@wsgr.com.
By:
/s/ Austin D. March
Austin D. March
Wilson Sonsini Goodrich & Rosati, P.C.
- 2 -
Show Raw Text
CORRESP 1 filename1.htm ekso20260330_corresp.htm Wilson Sonsini Goodrich & Rosati Professional Corporation 650 Page Mill Road Palo Alto, CA 94304-1050 O: 650.493.9300 f: 650.493.6811 March 30, 2026 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Technology 100 F Street, N.E. Washington, D.C. 20549-3720 Attn: Matthew Crispino Jan Woo Re: Ekso Bionics Holdings, Inc. Preliminary Information Statement Filed March 20, 2026 File No. 001-37854 Ladies and Gentlemen: On behalf of our client, Ekso Bionics Holdings, Inc. (the “ Company ”), we submit this letter in response to the comments contained in the letter dated March 27, 2026 (the “ Comment Letter ”) from the staff (the “ Staff ”) of the Securities and Exchange Commission (the “ SEC ”) relating to the above referenced Preliminary Information Statement on Schedule 14C (the “ Preliminary Information Statement ”) as filed by the Company on March 20, 2026. For your convenience, the text of the Staff’s comment is set forth below, by the Company’s response. Please note that all references to page numbers in the response below are references to the page numbers in Amendment No. 1 to the Preliminary Information Statement (the “ Amended Information Statement ”) submitted to the SEC concurrently with the submission of this letter. Preliminary Information Statement Opinion of Ekso’s Financial Advisor to the Board, page 41 1. We note that in performing its analyses and rendering its fairness opinion, Ekso's financial advisor, Lake Street Capital Markets LLC, relied on, among other things, internal financial analyses and forecasts prepared by Cloud's management. Please disclose the financial projections and other financial information furnished to Lake Street in the information statement. Refer to Item 1015(b)(6) of Regulation M-A. In response to the Staff’s comment, the Company has revised the disclosure on pages 45 and 46 of the Amended Information Statement. If you have any questions or comments regarding this letter and the responses set forth above, please direct the questions to me at (512) 338-5410 or amarch@wsgr.com. By: /s/ Austin D. March Austin D. March Wilson Sonsini Goodrich & Rosati, P.C. - 2 -